Development and Functional Characterization of Monoclonal Antibodies for Botulinum Neurotoxin Serotype A

Development and Functional Characterization of Monoclonal Antibodies for Botulinum Neurotoxin Serotype A

Botulinum neurotoxin serotype A (BoNT/A), the most toxic of the seven serotypes produced by Clostridium botulinum, poses significant public health risks because of its involvement in foodborne outbreaks and potential use in bioterrorism. In this study, we developed high-affinity monoclonal antibodie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingmei Kang, Qingyu Lv, Wenhua Huang, Hua Jiang, Shan Gao, Qian Li, Decong Kong, Guofen Zhao, Peng Liu, Yongqiang Jiang
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Foods
Subjects:	BoNT/A TRFIA rabbit mAb
Online Access:	https://www.mdpi.com/2304-8158/14/10/1743
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Botulinum Toxin in the Treatment of Patients with Upper Limb Spasticity After Stroke – a Systematic Review
by: Małgorzata Gucwa, et al.
Published: (2025-07-01)

Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01)

The role of botulinum toxin in the treatment of diseases beyond aesthetics: migraine, hyperhidrosis and bruxism - literature review
by: Karolina Oskroba, et al.
Published: (2025-05-01)

International Proficiency Test Targeting a Large Panel of Botulinum Neurotoxin Sero- and Subtypes in Different Matrices
by: Christine Rasetti-Escargueil, et al.
Published: (2024-11-01)

Foodborne Botulism Caused by <i>Clostridium botulinum</i> Subtype A5(b3) by Self-Packaged Vacuum Spicy Rabbit Heads
by: Wen Cui, et al.
Published: (2025-07-01)

High dose botox injection for treatment of high grade vesicoureteral reflux in a complicated pediatric case: A case report
by: Narjes Saberi, et al.
Published: (2025-05-01)

The Relationship Between Stiff Knee Gait Runner’s Dystonia and Musculoskeletal Knee Pathology: A Case Series
by: Jared A. Stowers, et al.
Published: (2025-03-01)

Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction
by: Yu-Shuang Lee, et al.
Published: (2025-06-01)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
by: Yuxin Chen, et al.
Published: (2021-01-01)

Effect of botulinum toxin type A on masticatory function and musculoskeletal structure in rabbits
by: Maha Mohamed Shehata Montaser, et al.
Published: (2025-05-01)

Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies
by: Arnaud Avril, et al.
Published: (2024-12-01)

Mucin 18‐targeted humanized monoclonal antibody immune positron emission tomography imaging and patient‐derived tumor xenograft visualization
by: Qian Zhang, et al.
Published: (2024-12-01)

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma
by: Léon Raymakers, et al.
Published: (2025-04-01)

Towards safer practices: A spotlight on foodborne botulism following the recent outbreak in Saudi Arabia in 2024
by: Muna Horabi, et al.
Published: (2024-12-01)

Botulism in cattle in Mato Grosso do Sul: History, current situation, and perspectives
by: Stephanie C. Lima, et al.
Published: (2024-11-01)

Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies
by: Chen Gurevitz, et al.
Published: (2024-12-01)

Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixtures
by: Tiexin Wang, et al.
Published: (2025-12-01)

A Simplified mAb-Based Antigen Detection Assay for Rapid Serotyping of Foot-and-Mouth Disease Virus
by: Mohammad A. Kashem, et al.
Published: (2025-05-01)

The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studies
by: Gao-Yuan Liu, et al.
Published: (2025-12-01)

Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity
by: Elaine Branstetter, et al.
Published: (2021-11-01)

Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies
by: Merve Celik Yamaci, et al.
Published: (2025-04-01)

Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MS
by: Laurence Whitty-Léveillé, et al.
Published: (2023-12-01)

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana
by: Kornchanok Sangprasat, et al.
Published: (2024-12-01)

Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
by: Ilaria Marrocco, et al.
Published: (2021-03-01)

The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells
by: Michaël Constantinides, et al.
Published: (2025-07-01)

Bibliometric analysis of monoclonal antibodies for atherosclerosis
by: Jiqing Ma, et al.
Published: (2023-12-01)

The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies
by: Ping Wang, et al.
Published: (2024-11-01)

A pivotal decade for bispecific antibodies?
by: Marlena Surowka, et al.
Published: (2024-12-01)

Dual-Toxin-Producing <i>Clostridium botulinum</i> Strain Isolated from a Foodborne Botulism Case in Korea: Genomic and Functional Insights
by: Eun-Sun Choi, et al.
Published: (2025-06-01)

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma
by: Yutian Zheng, et al.
Published: (2024-11-01)

Microfluidic Nanobiosensor Detection of Botulinum Neurotoxin Serotype A
by: Shruthi Srinivasan, et al.
Published: (2025-08-01)

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties
by: Hristo L. Svilenov, et al.
Published: (2023-12-01)

Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial
by: Abdallah Derbalah, et al.
Published: (2025-05-01)

The Use of Biotechnological Drugs in Pediatrics on the Example of Monoclonal Antibodies: Clinical Pharmacology View
by: Alexey S. Kolbin, et al.
Published: (2021-10-01)

Ion-exchange chromatography, capillary isoelectric focusing, and capillary zone electrophoresis coupled to mass spectrometry for charge variant analysis of monoclonal antibodies
by: Jasmin Schairer, et al.
Published: (2025-12-01)

An Effective Prophylactic and Therapeutic Protection Against Botulinum Type A Intoxication in Mice and Rabbits Using a Humanized Monoclonal Antibody
by: Chi Ho Yu, et al.
Published: (2025-03-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations
by: Ruiling Zhao, et al.
Published: (2025-03-01)

New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)